Clinical Trial
doi: 10.1038/bjc.1993.62.
A daily diary for quality of life measurement in advanced breast cancer trials
Affiliations
- PMID: 8431363
- PMCID: PMC1968179
- DOI: 10.1038/bjc.1993.62
Item in Clipboard
Clinical Trial
A daily diary for quality of life measurement in advanced breast cancer trials
Br J Cancer.
1993 Feb.
Free PMC article
Abstract
The Qualitator is a daily diary card to measure Quality of Life, developed for use in chemotherapy trials for patients with advanced breast cancer. In a trial at King's College Hospital, 29 patients completed the Qualitator and their scores were compared with scores in the Linear Analogue Self-Assessment and Nottingham Health Profile taken four-weekly. In a separate study at Guy's Hospital, 31 patients completed the diary. The Qualitator offers accurate prognostic data regarding subsequent UICC response and survival and is simple to use.
Similar articles
-
Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life.Br J Cancer. 1993 Feb;67(2):402-6. doi: 10.1038/bjc.1993.74. Br J Cancer. 1993. PMID: 8431375 Free PMC article. Clinical Trial.
-
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.J Clin Oncol. 1997 Jan;15(1):261-7. doi: 10.1200/JCO.1997.15.1.261. J Clin Oncol. 1997. PMID: 8996151 Clinical Trial.
-
The use of mitoxantrone in the treatment of breast cancer.Semin Oncol. 1995 Feb;22(1 Suppl 1):17-20. Semin Oncol. 1995. PMID: 7863347 Review. No abstract available.
-
Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23.Breast Cancer Res Treat. 2004 Jul;86(2):153-64. doi: 10.1023/B:BREA.0000032983.87966.4e. Breast Cancer Res Treat. 2004. PMID: 15319567 Clinical Trial.
-
Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter study.J Clin Oncol. 2003 Mar 1;21(5):843-50. doi: 10.1200/JCO.2003.05.135. J Clin Oncol. 2003. PMID: 12610183 Review.
Cited by
-
Efficacy of progressive muscle relaxation training and guided imagery in reducing chemotherapy side effects in patients with breast cancer and in improving their quality of life.Support Care Cancer. 2005 Oct;13(10):826-33. doi: 10.1007/s00520-005-0806-7. Epub 2005 Apr 23. Support Care Cancer. 2005. PMID: 15856335 Clinical Trial.
-
Single agent versus combination chemotherapy for metastatic breast cancer.Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD003372. doi: 10.1002/14651858.CD003372.pub3. Cochrane Database Syst Rev. 2009. PMID: 19370586 Free PMC article.
-
Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008.Health Qual Life Outcomes. 2009 Dec 23;7:102. doi: 10.1186/1477-7525-7-102. Health Qual Life Outcomes. 2009. PMID: 20030832 Free PMC article.
-
Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy.Br J Cancer. 1999 Apr;80(1-2):262-8. doi: 10.1038/sj.bjc.6690349. Br J Cancer. 1999. PMID: 10390006 Free PMC article. Clinical Trial.
-
Antitumour antibiotic containing regimens for metastatic breast cancer.Cochrane Database Syst Rev. 2004 Oct 18;2004(4):CD003367. doi: 10.1002/14651858.CD003367.pub2. Cochrane Database Syst Rev. 2004. PMID: 15495049 Free PMC article.
References
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
